Elsevier Presents Four New Books on Nuclear Engineering

WALTHAM, MA - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of four new nuclear engineering books of particular interest to safety managers, designers, engineers, operators and regulators of nuclear power plants. Among these new books is The 2011 Fukushima Nuclear Power Plant Accident: How and Why It Happened, written by Yotaro Hatamura, Seiji Abe, Masao Fuchigami and Naoto Kasahara, and translated by Kenji Iino.

• Download a free chapter from The 2011 Fukushima Nuclear Power Plant Accident here

Written by committee members of the official Japanese government investigation panel, The 2011 Fukushima Nuclear Power Plant Accident outlines the main sequence of events of the March 2011 accident, considers the responses of central and local government, and evaluates the response of the plant owner TEPCO. It describes and assesses the effectiveness of the evacuation process and subsequent decontamination of the site and local area. The book also offers recommendations for improving the safe design and operation of nuclear power plants.

The four new nuclear engineering books are:

• The 2011 Fukushima Nuclear Power Plant Accident: How and Why It Happened by Yotaro Hatamura, Seiji Abe, Masao Fuchigami, Naoto Kasahara and Kenji Iino
• Irradiation Embrittlement of Reactor Pressure Vessels (RPVs) in Nuclear Power Plants by Naoki Soneda
• Handbook of Small Modular Nuclear Reactors by Mario Carelli and Daniel Ingersoll
• Nuclear Energy: An Introduction to the Concepts, Systems, and Applications of Nuclear Processes, 7th Edition by Raymond Murray and Keith Holbert

The books are available on the Elsevier Store and on ScienceDirect, Elsevier's full-text scientific database offering journal articles and book chapters from over 2,200 peer-reviewed journals and more than 25,000 book titles.

Notes for Editors
Review copies of the books are available to credentialed journalists upon request. Contact Michelle McMahon at m.mcmahon.1@elsevier.com or +1 781 663 2268.

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are (EURONEXT AMSTERDAM: REN) (LSE: REL) (NYSE: RUK) (NYSE: ENL).

Image Available: http://www.marketwire.com/library/MwGo/2014/12/15/11G028585/Images/The_2011_Fukushima_Nuclear_Power_Plant_Accident_hi-757823585877.jpg
Image Available: http://www.marketwire.com/library/MwGo/2014/12/15/11G028585/Images/Handbook_of_Small_Modular_Nuclear_Reactors_Ch4Fig1-1399191362666.gif
Image Available: http://www.marketwire.com/library/MwGo/2014/12/15/11G028585/Images/Irradiation_Embrittlement_of_Reactor_Pressure_Vess-1377981921244.jpg

To post a comment, you must register and login.